Cargando…

The clinical manifestations and management of COVID-19-related liver injury

Detalles Bibliográficos
Autores principales:	Su, Tung-Hung, Kao, Jia-Horng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Formosan Medical Association. Published by Elsevier Taiwan LLC. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180368/ https://www.ncbi.nlm.nih.gov/pubmed/32345544 http://dx.doi.org/10.1016/j.jfma.2020.04.020

Ejemplares similares

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2014)

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
por: Huang, Shang-Chin, et al.
Publicado: (2021)

COVID-19: Gastrointestinal manifestations, liver injury and recommendations
por: Ozkurt, Zulal, et al.
Publicado: (2022)

Pathogenesis and management of alcoholic liver cirrhosis: a review
por: Huang, Yi-wen, et al.
Publicado: (2011)

Gastrointestinal and Liver Manifestations of COVID-19
por: Agarwal, Amol, et al.
Publicado: (2020)

Gastrointestinal and liver manifestations of COVID-19
por: Cheong, Janice, et al.
Publicado: (2020)

Liver injury in COVID-19: clinical features and treatment management
por: Yu, Dongdong, et al.
Publicado: (2021)

Gastrointestinal and Liver Manifestations in Children with COVID-19 and Their Relationship to Clinical Course
por: Alkan, Gülsüm, et al.
Publicado: (2022)

Gastrointestinal and Liver Manifestations in COVID-19 Population
por: Saleem, Saad, et al.
Publicado: (2021)

Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management
por: Li, Xichuan, et al.
Publicado: (2022)

Gastrointestinal and liver manifestations in patients with COVID-19
por: Lee, I-Cheng, et al.
Publicado: (2020)

The early stage of COVID-19 pandemic: Gastrointestinal manifestations and liver injury in COVID-19 patients in Wuhan, China
por: Chen, Dafan, et al.
Publicado: (2022)

Liver Injury in COVID-19: Caution and Management
por: Cao, Jiasheng, et al.
Publicado: (2020)

Liver injury in COVID-19: management and challenges
por: Zhang, Chao, et al.
Publicado: (2020)

Radiographic and clinical neurologic manifestations of COVID-19 related hypoxemia
por: Radnis, Caitlin, et al.
Publicado: (2020)

Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management
por: Cnossen, Wybrich R, et al.
Publicado: (2014)

Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease
por: Lin, Meng-Ju, et al.
Publicado: (2023)

Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance
por: Yang, Hung-Chih, et al.
Publicado: (2014)

Remarkable gastrointestinal and liver manifestations of COVID-19: A clinical and radiologic overview
por: Fang, Li-Guang, et al.
Publicado: (2021)

Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease
por: Lin, Meng-Ju, et al.
Publicado: (2023)

Clinical characteristics and manifestations in older patients with COVID-19
por: Wei, Chenchen, et al.
Publicado: (2020)

COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management
por: Sattar, Yasar, et al.
Publicado: (2020)

COVID-19 related liver injuries in pregnancy
por: Sekulovski, Metodija, et al.
Publicado: (2023)

Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury—The Current State of Knowledge and Future Perspectives
por: Smarz-Widelska, Iwona, et al.
Publicado: (2021)

COVID-19 Pathogenesis and Clinical Manifestations
por: Hernandez Acosta, R. Alfonso, et al.
Publicado: (2022)

Etiology and management of liver injury in patients with COVID-19
por: Yang, Rui-Xu, et al.
Publicado: (2020)

COVID-19–Associated Endothelial Dysfunction and Microvascular Injury: From Pathophysiology to Clinical Manifestations
por: Canale, Maria Paola, et al.
Publicado: (2022)

Cutaneous manifestations of COVID‐19: diagnosis and management
por: Seebacher, Nicole, et al.
Publicado: (2022)

COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management
por: Li, Penghui, et al.
Publicado: (2022)

Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease
por: Cheng, Yu-Ming, et al.
Publicado: (2023)

Otorhinolaryngological Manifestations and Its Management in COVID 19 Patients
por: Borah, Hironya, et al.
Publicado: (2021)

Impact of COVID-19 on Nonpulmonary Critical Illness: Prevalence, Clinical Manifestations, Management, and Outcomes
por: Pirzadeh, Mina, et al.
Publicado: (2023)

COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations
por: Bhurwal, Abhishek, et al.
Publicado: (2021)

Liver manifestations in COVID-19 patients: A review article
por: Helou, Mariana, et al.
Publicado: (2023)

Encephalitis as a clinical manifestation of COVID-19
por: Ye, Mingxiang, et al.
Publicado: (2020)

Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes
por: Janjua, Omer Sefvan, et al.
Publicado: (2021)

Extrapulmonary Clinical Manifestations in COVID-19 Patients
por: Sarkesh, Aila, et al.
Publicado: (2020)

COVID-19 and the clinical course of rheumatic manifestations
por: Ahmed, Sakir, et al.
Publicado: (2021)

Acute Liver Injury as a Manifestation of Secondary Syphilis
por: Shah, Jamil, et al.
Publicado: (2021)

COVID-19 combined with liver injury: Current challenges and management
por: Deng, Man-Ling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pvph8o68n3fbh8n6q8t9alnph7